Pharmaceutical Technology26d agobullish
MSD wins FDA approval for cholesterol pill to help plug Keytruda voidMSD has outpaced rivals to market the first PCSK9 inhibitor in pill form for patients with high cholesterol.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
328last 24h
2140last 7d
379● bullish (7d)
188● bearish (7d)
204publishers
Insider Monkey46d agobullish
Gilead (GILD) Wins FDA Approval for Trodelvy in TNBCGilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]